Table 2.
Hematological indicators | Case group (n=50) | Control group (n=55) | P value |
---|---|---|---|
LDH | 0.030 | ||
Increase | 28 | 29 | |
Non-increase | 22 | 26 | |
β2-MG | 0.774 | ||
Increase | 34 | 38 | |
Non-increase | 16 | 27 | |
ESR | 0.000 | ||
Increase | 42 | 38 | |
Non-increase | 8 | 19 | |
Plasma albumin | 0.773 | ||
Decrease | 34 | 37 | |
Non-decrease | 16 | 18 | |
Plasma globulin | 0.705 | ||
Increase | 14 | 17 | |
Non-increase | 36 | 38 | |
leukocyte count | 0.668 | ||
Increase | 29 | 28 | |
Non-increase | 21 | 27 | |
Absolute value of lymphocytes | 0.692 | ||
Increase | 11 | 10 | |
Non-increase | 39 | 40 | |
Medullary inhibition | 0.063 | ||
I-II degree | 32 | 34 | |
III-IV degree | 18 | 21 | |
Hemoglobin | 0.860 | ||
Diminished | 15 | 20 | |
Undiminished | 35 | 30 |
Note: Increase: the difference of this index before and after chemotherapy was positive; Non-increase/non-decrease: the difference of this index before and after chemotherapy was negative or zero; Decrease: the difference of this index before and after chemotherapy was negative.